HR 9077
  • Introduced
    May 29, 2026
  • Passed House
  • Passed Senate
  • Became Law
HR 9077
United States House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
Last Action See all actions
House • May 29, 2026: Referred to the House Committee on Energy and Commerce.

Summary

Comments on HR 9077

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • May 29, 2026 | House
    • Introduced in House
    • Referred to the House Committee on Energy and Commerce.
Bill Texts
Looks like there aren't any bill texts available at this moment.
Documents
Looks like we don't have any documents available at this moment.
Sources